We are live on ! Find out more
FFA

First Foundation Advisors Portfolio holdings

AUM $2.48B
1-Year Est. Return 18.56%
This Fund
S&P 500
This Quarter Est. Return
-5.87%
1 Year Est. Return
+18.56%
3 Year Est. Return
+57.06%
5 Year Est. Return
+72.87%
10 Year Est. Return
+256.29%
AUM
$1.22B
AUM Growth
-$40.7M
Cap. Flow
+$370M
Cap. Flow %
30.39%
Top 10 Hldgs %
33.19%
Holding
272
New
27
Increased
95
Reduced
84
Closed
32

Top Buys

Rank Stock Value
1
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$321M
2
MRK icon
Merck
MRK
+$18.5M
3
MDT icon
Medtronic
MDT
+$13.7M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$11.6M
5
MON
Monsanto Co
MON
+$11.5M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$16.8M
2
BUD icon
AB InBev
BUD
+$10.9M
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$9.61M
4
TEF
Telefonica
TEF
+$8.75M
5
DIS icon
Walt Disney
DIS
+$8.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.79%
2 Financials 12.61%
3 Consumer Staples 12.43%
4 Technology 11.6%
5 Industrials 8.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VWTR
51
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$5.99M 0.49%
619,145
+424,217
+218% +$5.3M
PFN
52
PIMCO Income Strategy Fund II
PFN
$694M
$5.88M 0.48%
664,610
+39,203
+6% +$362K
GILD icon
53
Gilead Sciences
GILD
$162B
$5.78M 0.47%
58,819
-899
-2% -$99.8K
PTY icon
54
PIMCO Corporate & Income Opportunity Fund
PTY
$2.48B
$5.5M 0.45%
413,787
+200,075
+94% +$2.78M
TEVA icon
55
Teva Pharmaceuticals
TEVA
$40.9B
$5.3M 0.44%
93,830
+41,872
+81% +$2.71M
NBB icon
56
Nuveen Taxable Municipal Income Fund
NBB
$446M
$4.57M 0.38%
232,655
+4,872
+2% +$95K
BBN icon
57
BlackRock Taxable Municipal Bond Trust
BBN
$975M
$4.51M 0.37%
223,719
-20,970
-9% -$421K
ROIC
58
DELISTED
Retail Opportunity Investments Corp.
ROIC
$4.49M 0.37%
271,178
+13,856
+5% +$229K
DBL
59
DoubleLine Opportunistic Credit Fund
DBL
$278M
$4.47M 0.37%
179,833
-2,841
-2% -$67.6K
TEI
60
Templeton Emerging Markets Income Fund
TEI
$315M
$4.45M 0.37%
459,470
-45,555
-9% -$466K
BIIB icon
61
Biogen
BIIB
$30.3B
$4.29M 0.35%
+14,708
New +$4.86M
JGH icon
62
Nuveen Global High Income Fund
JGH
$351M
$4.07M 0.33%
281,981
+62,558
+29% +$979K
KO icon
63
Coca-Cola
KO
$377B
$3.97M 0.33%
98,873
+741
+0.8% +$29.7K
JPC icon
64
Nuveen Preferred & Income Opportunities Fund
JPC
$2.89B
$3.83M 0.31%
426,574
+26,134
+7% +$240K
STWD icon
65
Starwood Property Trust
STWD
$5.93B
$3.44M 0.28%
167,448
+3,906
+2% +$84.6K
SJNK icon
66
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
$3.19M 0.26%
118,610
-15,091
-11% -$422K
BRK.A icon
67
Berkshire Hathaway Class A
BRK.A
$1.1T
$3.12M 0.26%
1,600
+1,559
+3,802% +$321M
BTZ icon
68
BlackRock Credit Allocation Income Trust
BTZ
$934M
$3.09M 0.25%
254,230
+21,203
+9% +$263K
GSK icon
69
GSK
GSK
$104B
$3.06M 0.25%
63,711
-322,882
-84% -$16.8M
VOO icon
70
Vanguard S&P 500 ETF
VOO
$977B
$3.02M 0.25%
+17,166
New +$3.19M
FTD
71
DELISTED
FTD Companies, Inc. Common Stock
FTD
$2.89M 0.24%
97,104
+19,585
+25% +$578K
DFP
72
Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP
$427M
$2.86M 0.23%
127,659
+8,233
+7% +$183K
JPS
73
DELISTED
Nuveen Preferred & Income Securities Fund
JPS
$2.67M 0.22%
305,201
+34,217
+13% +$308K
EVV
74
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
$2.62M 0.22%
206,811
+19,599
+10% +$261K
DWA
75
DELISTED
DREAMWORKS ANIMATION SKG INC CL-A
DWA
$2.55M 0.21%
146,021
+118,424
+429% +$2.56M
1 2
3
4 5

Similar funds

BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
BW
BIP Wealth Atlanta, Georgia $2.46B AUM 14.38% 1-Year Est. Return

First Foundation Advisors's Q3 2015 Portfolio in Review

As of Q3 2015, First Foundation Advisors held 272 positions worth $1.22B, down 3.2% from $1.26B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

First Foundation Advisors deployed $370M of net new capital in Q3 2015, opening 27 new positions and adding to 95 existing holdings. Its largest new stake was Biogen: 14,708 shares worth $4.29M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was GSK, an estimated $16.8M trimmed.

  • First Foundation Advisors's largest Q3 2015 buy was Biogen: 14,708 shares worth $4.29M.
  • First Foundation Advisors added most to Berkshire Hathaway Class A in Q3 2015, an estimated $321M increase.
  • First Foundation Advisors's biggest Q3 2015 reduction was GSK, cutting an estimated $16.8M.
  • First Foundation Advisors fully exited NRG Energy in Q3 2015, selling an estimated $1.6M.
  • First Foundation Advisors's ten largest holdings make up 33% of its $1.22B portfolio in Q3 2015.
  • First Foundation Advisors opened 27 new positions and closed 32 in Q3 2015.
  • First Foundation Advisors's portfolio value fell 3.2% quarter-over-quarter to $1.22B.

Based on First Foundation Advisors's 13F filing for Q3 2015, filed 16 Nov 2015.